From Rat Studies to Human Extrapolation From rat studies, the remarkably consistent effective dose range of 0.0045 mg/lb to 0.0000045 mg/lb intraperitoneally (a 1000-fold range showing similar efficacy) worked across depression, anxiety, Parkinsons, stroke, schizophrenia, and seizure models
Further, it inhibits 4-hydroxynoneal, a molecule produced in the body that negatively impacts cellular growth
One peptide that stands out is the TB 500 peptide, known for its tissue repair and flexibility benefits
GHK-Cu (50mg), a copper-bound tripeptide first isolated from human blood plasma in 1973
This is fortunate, due to the invasive nature of this delivery method
This combination forms a complementary treatment